KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1

Suzan Ber,Ming Yang,Marco Sciacovelli,Shamith Samarajiwa,Khushali Patel,Efterpi Nikitopoulou,Annie Howitt,Simon J Cook,Ashok R. Venkitaraman,Christian Frezza,Alessandro Esposito

DOI: https://doi.org/10.1101/2024.10.19.618135

2024-10-22

Abstract:Mutations in KRAS, particularly at codon 12, are frequent in adenocarcinomas of the colon, lungs and pancreas, driving oncogenic processes through altered cell signalling and metabolism. However, the specific mechanisms by which different KRAS G12 alleles contribute to distinct metabolic reprogramming remain unclear. Using isogenic panels of colorectal cell lines harbouring the G12A, G12C, G12D and G12V heterozygous mutations and employing transcriptomics, metabolomics, and extensive biochemical validation, we demonstrate distinctive features of each allele. We demonstrate that cells harbouring the common G12D and G12V oncogenic mutations significantly alter glutamine metabolism and nitrogen recycling through FOXO1-mediated regulation compared to other mutant and parental lines. With a combination of small molecule inhibitors targeting glutamine metabolism, we also identify a common vulnerability that eliminates mutant cells selectively. These results highlight a previously unreported mutant-specific effect of KRAS alleles on metabolism and signalling that can be harnessed for cancer therapy.

Cancer Biology